Isradipine ( DrugBank: Isradipine )

---

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
6	パーキンソン病	3

6. パーキンソン病

---

臨床試験数 : 2,307 /  薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02168842 (ClinicalTrials.gov)	November 2014	18/6/2014	Efficacy of Isradipine in Early Parkinson Disease	Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease	Parkinson Disease	Drug: Isradipine;Drug: Placebo (for Isradipine)	University of Rochester	National Institute of Neurological Disorders and Stroke (NINDS);Michael J. Fox Foundation for Parkinson's Research;The Parkinson Study Group	Completed	30 Years	N/A	All	336	Phase 3	United States;Canada
2	NCT00909545 (ClinicalTrials.gov)	July 2009	26/5/2009	Safety, Tolerability and Efficacy Assessment of Dynacirc CR in Parkinson Disease	A Pilot Phase II Double-Blind, Placebo-Controlled, Tolerability and Dosage Finding Study of Isradipine CR as a Disease Modifying Agent in Patients With Early Parkinson Disease	Parkinson Disease	Drug: Isradipine CR 5mg;Drug: Isradipine CR 10mg;Drug: Isradipine CR 20mg;Drug: Placebo	Northwestern University	Michael J. Fox Foundation for Parkinson's Research;Northwestern University Dixon Fund;The Parkinson Study Group	Completed	30 Years	N/A	All	99	Phase 2	United States;Canada
3	NCT00753636 (ClinicalTrials.gov)	April 2008	13/9/2008	Parkinson's Disease Isradipine Safety Study	Phase II Safety and Tolerability of Isradipine (A Potential Neuroprotective Agent) in Patients With Parkinson's Disease- Stage II	Parkinson's Disease	Drug: Dynacirc CR (Isradipine)	Northwestern University	Northwestern Memorial Hospital	Completed	30 Years	75 Years	All	31	Phase 2	United States